Pfeiffer P, Asmussen L, Kvist-Poulsen H, Bertelsen K
Department of Oncology, Odense University Hospital, Denmark.
Gynecol Oncol. 1989 Oct;35(1):47-9. doi: 10.1016/0090-8258(89)90009-7.
Intraperitoneal administration of chemotherapy in ovarian cancer is currently under investigation. In this preliminary report we introduce the "Veress-needle" as a "single-use" delivery system of intraperitoneal chemotherapy. A total of 22 infusions in 7 patients revealed no major complications, and during 4 infusions only minor side effects were noted. The technique described seems to fulfill the need for a safe, reliable, and acceptable delivery system of intraperitoneal chemotherapy.
目前正在研究卵巢癌腹腔内化疗。在这份初步报告中，我们介绍了“韦雷斯针”作为腹腔内化疗的“一次性”给药系统。7例患者共进行了22次输注，未发现重大并发症，仅在4次输注期间出现轻微副作用。所描述的技术似乎满足了腹腔内化疗安全、可靠且可接受的给药系统的需求。
